✦ LIBER ✦

PCV42 INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS IN A US MANAGED CARE POPULATION

✍ Scribed by LA Miller; R Wade; MJ Cziraky; D Dai; K Mayo; K Ramsawany

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Cost-Effectiveness Analysis of Angiote

✍ Panagiotis C. Stafylas; Pantelis A. Sarafidis; Dimitrios M. Grekas; Anastasios N 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 230 KB

Blood Pressure Outcomes in Patients Rece

✍ C. Venkata S. Ram; Krishnan Ramaswamy; Chunlin Qian; Joe Biskupiak; Amy Ryan; Ru 📂 Article 📅 2011 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 468 KB

PCV14 A COMPARISON OF BLOOD PRESSURE OUT

✍ J Biskupiak; J Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN44 ASSESSMENT OF HEALTH CARE UTILIZAT

✍ S Ray; A Ganguli; Y Luo; Y Xu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-effectiveness of renoprotection in

✍ Dean G. Smith; Giancarlo Viberti; Anh Nguyen; Feride F. Frech; Krista Yokoyama 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Human epidermal growth factor receptor 2

✍ Patricia R. Blank; Matthias Schwenkglenks; Holger Moch; Thomas D. Szucs 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 374 KB